Ruslan F. Mykytenko
Research Subjects
Ruslan F. Mykytenko has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Borys M. Todurov
Shupyk National Healthcare University of Ukraine, Kyiv
4 shared publications - Gavrylo I. Kovtun
Heart Institute of the Ministry of Health of Ukraine, Ukraine
2 shared publications - Oleg V. Zelenchuk
Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine; Heart Institute of the Ministry of Health of Ukraine, Kyiv, Ukraine
2 shared publications - Yurii V. Hutsuliak
Heart Institute of the Ministry of Health of Ukraine, Kyiv, Ukraine
2 shared publications - A. V. Markovets1 shared publication
- Alexandros Mourtarakos1 shared publication
Latest Publications
- Open Access
- 31 March 2026
- Published by Chetverta Khvylia in Cardiac Surgery and Interventional Cardiology
- Vol. 15 (1) , 66-71
Хірургічне лікування гігантської аневризми правої коронарної артерії, ускладненої масивним тромбозом: клінічний випадок
Coronary artery aneurysm is a relatively rare pathology that may be complicated by thrombosis, embolization, or rupture. Giant aneurysms, particularly those containing an intraluminal thrombus, are associated with a high risk of acute coronary events and require timely determination of the optimal treatment strategy.The aim – to present a clinical case of successful surgical treatment of a giant right coronary artery (RCA) aneurysm complicated by massive intraluminal thrombosis and to justify the choice of aneurysm resection with simultaneous myocardial revascularization.We describe a 68-year-old patient with comorbidities (arterial hypertension, type 2 diabetes mellitus, and dyslipidemia) who presented with progressive chest pain for three days. The initial evaluation included laboratory tests, electrocardiography, and chest radiography. Coronary angiography with ventriculography was performed to assess the coronary circulation and revealed a giant saccular aneurysm of the proximal RCA measuring up to 50 mm, with a massive thrombus within the aneurysmal cavity. Surgery was performed via median sternotomy under cardiopulmonary bypass. The procedure included coronary artery bypass grafting (to the RCA and the left anterior descending artery), opening of the aneurysm, complete removal of thrombotic masses, resection of the aneurysmal sac, and subsequent closure.Results. The postoperative period was uneventful. Follow-up echocardiography demonstrated preserved left ventricular systolic function without signs of ischemia. The patient was discharged on postoperative day 8 in stable condition with recommendations for secondary prevention and a plan for follow-up monitoring. Control computed tomography performed one month later confirmed graft patency and the absence of aneurysm recurrence. During 12 months of follow-up, the patient reported no recurrent angina and experienced no cardiovascular events.Conclusions. Giant RCA aneurysms, particularly those complicated by massive thrombosis, carry a high risk of thromboembolic complications and require an active treatment strategy. Aneurysm resection combined with coronary artery bypass grafting is an effective and safe approach that eliminates a source of embolization and provides adequate myocardial revascularization.
- 31 March 2026
- Published by Chetverta Khvylia in Cardiac Surgery and Interventional Cardiology
- Vol. 15 (1) , 66-71
Open AccessХірургічне лікування гігантської аневризми правої коронарної артерії, ускладненої масивним тромбозом: клінічний випадок
Coronary artery aneurysm is a relatively rare pathology that may be complicated by thrombosis, embolization, or rupture. Giant aneurysms, particularly those containing an intraluminal thrombus, are associated with a high risk of acute coronary events and require timely determination of the optimal treatment strategy.The aim – to present a clinical case of successful surgical treatment of a giant right coronary artery (RCA) aneurysm complicated by massive intraluminal thrombosis and to justify the choice of aneurysm resection with simultaneous myocardial revascularization.We describe a 68-year-old patient with comorbidities (arterial hypertension, type 2 diabetes mellitus, and dyslipidemia) who presented with progressive chest pain for three days. The initial evaluation included laboratory tests, electrocardiography, and chest radiography. Coronary angiography with ventriculography was performed to assess the coronary circulation and revealed a giant saccular aneurysm of the proximal RCA measuring up to 50 mm, with a massive thrombus within the aneurysmal cavity. Surgery was performed via median sternotomy under cardiopulmonary bypass. The procedure included coronary artery bypass grafting (to the RCA and the left anterior descending artery), opening of the aneurysm, complete removal of thrombotic masses, resection of the aneurysmal sac, and subsequent closure.Results. The postoperative period was uneventful. Follow-up echocardiography demonstrated preserved left ventricular systolic function without signs of ischemia. The patient was discharged on postoperative day 8 in stable condition with recommendations for secondary prevention and a plan for follow-up monitoring. Control computed tomography performed one month later confirmed graft patency and the absence of aneurysm recurrence. During 12 months of follow-up, the patient reported no recurrent angina and experienced no cardiovascular events.Conclusions. Giant RCA aneurysms, particularly those complicated by massive thrombosis, carry a high risk of thromboembolic complications and require an active treatment strategy. Aneurysm resection combined with coronary artery bypass grafting is an effective and safe approach that eliminates a source of embolization and provides adequate myocardial revascularization.
- 30 March 2026
- Published by Sumy State University in Eastern Ukrainian Medical Journal
- Vol. 14 (1)
SURGICAL TREATMENT OF TRICUSPID VALVE PATHOLOGIES. INDICATIONS AND COMPLICATIONS: SYSTEMATIC LITERATURE REVIEW
Tricuspid valve (TV) disease, in particular, tricuspid regurgitation (TR), has historically received less attention than mitral pathologies, often leading to delayed intervention and suboptimal outcomes. With growing evidence of TR’s independent contribution to morbidity and mortality, surgical and transcatheter treatment strategies have rapidly evolved in recent years. Objective. This systematic review aimed to synthesize modern data on the indications, procedural strategies, outcomes, and complications associated with surgical and transcatheter management of tricuspid valve disease. Methods. The review was conducted following PRISMA 2020 guidelines. Searches were performed in PubMed, Scopus, and Web of Science for studies published between January 1 2020 and May 30 2025. Studies were screened for eligibility based on predefined inclusion and exclusion criteria. Risk of bias was assessed using the Cochrane RoB 2 tool for randomized controlled trials and the ROBINS-I tool for cohort studies. Data were extracted on intervention types, functional outcomes, procedural complications, and patient selection criteria. Results. Thirty-six studies met inclusion criteria, including 10 systematic reviews. Transcatheter approaches – particularly TriClip, EVOQUE, and LuX-Valve – demonstrated favorable safety and symptom improvement in high-risk populations. Surgical intervention remains the standard for anatomically suitable patients, especially when performed early. Functional gains were consistent across modalities, but long-term durability and recurrence rates varied. Risk of bias was low in the lone randomized controlled trial (RCT) and moderate in most cohort studies. Conclusions. Surgical and transcatheter treatments for TV disease each offer distinct advantages based on patient selection and disease stage. Continued standardization of outcome reporting and expansion of randomized trials are critical to optimizing care strategies.
- 30 March 2026
- Published by Sumy State University in Eastern Ukrainian Medical Journal
- Vol. 14 (1)
SURGICAL TREATMENT OF TRICUSPID VALVE PATHOLOGIES. INDICATIONS AND COMPLICATIONS: SYSTEMATIC LITERATURE REVIEW
Tricuspid valve (TV) disease, in particular, tricuspid regurgitation (TR), has historically received less attention than mitral pathologies, often leading to delayed intervention and suboptimal outcomes. With growing evidence of TR’s independent contribution to morbidity and mortality, surgical and transcatheter treatment strategies have rapidly evolved in recent years. Objective. This systematic review aimed to synthesize modern data on the indications, procedural strategies, outcomes, and complications associated with surgical and transcatheter management of tricuspid valve disease. Methods. The review was conducted following PRISMA 2020 guidelines. Searches were performed in PubMed, Scopus, and Web of Science for studies published between January 1 2020 and May 30 2025. Studies were screened for eligibility based on predefined inclusion and exclusion criteria. Risk of bias was assessed using the Cochrane RoB 2 tool for randomized controlled trials and the ROBINS-I tool for cohort studies. Data were extracted on intervention types, functional outcomes, procedural complications, and patient selection criteria. Results. Thirty-six studies met inclusion criteria, including 10 systematic reviews. Transcatheter approaches – particularly TriClip, EVOQUE, and LuX-Valve – demonstrated favorable safety and symptom improvement in high-risk populations. Surgical intervention remains the standard for anatomically suitable patients, especially when performed early. Functional gains were consistent across modalities, but long-term durability and recurrence rates varied. Risk of bias was low in the lone randomized controlled trial (RCT) and moderate in most cohort studies. Conclusions. Surgical and transcatheter treatments for TV disease each offer distinct advantages based on patient selection and disease stage. Continued standardization of outcome reporting and expansion of randomized trials are critical to optimizing care strategies.
- Open Access
- 20 January 2026
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 1,p. 16-24
SURGICAL TRICUSPID VALVE REPAIR: RING ANNULOPLASTY AND DE VEGA TECHNIQUE. IMMEDIATE POSTOPERATIVE RESULTS COMPARISON
Introduction. Tricuspid regurgitation is associated with progressive right heart failure and increased mortality. The two principal repair techniques are ring annuloplasty (rigid prosthetic ring implantation) and the De Vega suture annuloplasty. Aim. Comparison of short-term results in 32 patients with severe functional tricuspid regurgitation, divided into two equal groups, based on the technique used: Group I (ring annuloplasty) (n=16) and Group II (De Vega suture annuloplasty) (n=16). Materials and methods. Preoperative characteristics, intraoperative data, and postoperative outcomes were collected. Statistical analysis compared group differences in early mortality, complications, and tricuspid regurgitation recurrence. Results were contextualized with contemporary studies and guidelines. Results. Both groups achieved significant reduction of tricuspid regurgitation grade from severe preoperatively to mild or less in most patients at discharge. Residual moderate tricuspid regurgitation was low in both groups (12.5% vs 18.8%, p>0.5). There was no significant difference in early postoperative complications. One in-hospital death occurred in Group I (6.3% mortality) vs. none in Group II. Postoperative echocardiography showed marked reduction in right atrial size and pulmonary artery systolic pressure in both groups (mean pulmonary artery systolic pressure ~44–48 mmHg postoperatively, down from ~60–64 mmHg preoperatively). Left ventricular ejection fraction was mildly improved (from ~56% to 60% in Group I, ~60% to 62% in Group II). Conclusions. Both ring annuloplasty and De Vega suture repair are effective in the early postoperative period, with comparable improvements in hemodynamics and tricuspid regurgitation severity at discharge. However, given the high recurrence rate of suture annuloplasty over time and evidence of improved long-term survival and freedom from tricuspid regurgitation with ring annuloplasty, the use of a prosthetic ring is recommended as the preferred technique for functional tricuspid regurgitation repair whenever feasible.
- 20 January 2026
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 1,p. 16-24
Open AccessSURGICAL TRICUSPID VALVE REPAIR: RING ANNULOPLASTY AND DE VEGA TECHNIQUE. IMMEDIATE POSTOPERATIVE RESULTS COMPARISON
Introduction. Tricuspid regurgitation is associated with progressive right heart failure and increased mortality. The two principal repair techniques are ring annuloplasty (rigid prosthetic ring implantation) and the De Vega suture annuloplasty. Aim. Comparison of short-term results in 32 patients with severe functional tricuspid regurgitation, divided into two equal groups, based on the technique used: Group I (ring annuloplasty) (n=16) and Group II (De Vega suture annuloplasty) (n=16). Materials and methods. Preoperative characteristics, intraoperative data, and postoperative outcomes were collected. Statistical analysis compared group differences in early mortality, complications, and tricuspid regurgitation recurrence. Results were contextualized with contemporary studies and guidelines. Results. Both groups achieved significant reduction of tricuspid regurgitation grade from severe preoperatively to mild or less in most patients at discharge. Residual moderate tricuspid regurgitation was low in both groups (12.5% vs 18.8%, p>0.5). There was no significant difference in early postoperative complications. One in-hospital death occurred in Group I (6.3% mortality) vs. none in Group II. Postoperative echocardiography showed marked reduction in right atrial size and pulmonary artery systolic pressure in both groups (mean pulmonary artery systolic pressure ~44–48 mmHg postoperatively, down from ~60–64 mmHg preoperatively). Left ventricular ejection fraction was mildly improved (from ~56% to 60% in Group I, ~60% to 62% in Group II). Conclusions. Both ring annuloplasty and De Vega suture repair are effective in the early postoperative period, with comparable improvements in hemodynamics and tricuspid regurgitation severity at discharge. However, given the high recurrence rate of suture annuloplasty over time and evidence of improved long-term survival and freedom from tricuspid regurgitation with ring annuloplasty, the use of a prosthetic ring is recommended as the preferred technique for functional tricuspid regurgitation repair whenever feasible.
- Open Access
- 3 December 2025
- Published by Chetverta Khvylia in Cardiac Surgery and Interventional Cardiology
- Vol. 14 (3) , 7-14
Early outcomes of surgical treatment in patients with combined aortic and mitral valve pathology and concomitant coronary artery disease
The aim – to evaluate the clinical outcomes of surgical treatment in patients with combined aortic and mitral valve disease in the setting of concomitant coronary artery disease (CAD), who underwent simultaneous valve replacement and coronary artery bypass grafting (CABG), with analysis of preoperative, intraoperative, and postoperative parameters. Materials and methods. A retrospective analysis of 35 cases of combined surgical interventions (AVR + MVR + CABG), performed at the Heart Institute of the Ministry of Health of Ukraine between 2019 and 2023, was conducted. The study assessed clinical characteristics, echocardiographic findings, intraoperative data, postoperative course, complications, and mortality rates. Risk stratification was performed using EuroSCORE II and the STS Risk Calculator.Results. In patients with severe multivalvular disease (n = 35), mitral regurgitation (100 %) and concomitant heart failure (94.3 %) were predominant. Postoperative improvement of NYHA class was observed in 74.3 % of cases. Mortality rate was 14.3 %, with infectious (51 %) and neurological (39 %) complications being common. Atrial fibrillation was associated with higher mortality. Postoperative echocardiography showed improved hemodynamics. These findings confirm the effectiveness of combined surgical intervention when careful patient selection is ensured.Conclusions. Simultaneous aortic and mitral valve replacement combined with coronary artery bypass grafting (CABG) represents a clinically justified surgical strategy for patients with combined valvular pathology and coronary artery disease, including those at intermediate and high risk according to the EuroSCORE II and STS scales. Despite acceptable survival rates, the incidence of postoperative complications remains significant, due to acute kidney injury, stroke, infections, ventricular fibrillation, and the need for reinterventions).
- 3 December 2025
- Published by Chetverta Khvylia in Cardiac Surgery and Interventional Cardiology
- Vol. 14 (3) , 7-14
Open AccessEarly outcomes of surgical treatment in patients with combined aortic and mitral valve pathology and concomitant coronary artery disease
The aim – to evaluate the clinical outcomes of surgical treatment in patients with combined aortic and mitral valve disease in the setting of concomitant coronary artery disease (CAD), who underwent simultaneous valve replacement and coronary artery bypass grafting (CABG), with analysis of preoperative, intraoperative, and postoperative parameters. Materials and methods. A retrospective analysis of 35 cases of combined surgical interventions (AVR + MVR + CABG), performed at the Heart Institute of the Ministry of Health of Ukraine between 2019 and 2023, was conducted. The study assessed clinical characteristics, echocardiographic findings, intraoperative data, postoperative course, complications, and mortality rates. Risk stratification was performed using EuroSCORE II and the STS Risk Calculator.Results. In patients with severe multivalvular disease (n = 35), mitral regurgitation (100 %) and concomitant heart failure (94.3 %) were predominant. Postoperative improvement of NYHA class was observed in 74.3 % of cases. Mortality rate was 14.3 %, with infectious (51 %) and neurological (39 %) complications being common. Atrial fibrillation was associated with higher mortality. Postoperative echocardiography showed improved hemodynamics. These findings confirm the effectiveness of combined surgical intervention when careful patient selection is ensured.Conclusions. Simultaneous aortic and mitral valve replacement combined with coronary artery bypass grafting (CABG) represents a clinically justified surgical strategy for patients with combined valvular pathology and coronary artery disease, including those at intermediate and high risk according to the EuroSCORE II and STS scales. Despite acceptable survival rates, the incidence of postoperative complications remains significant, due to acute kidney injury, stroke, infections, ventricular fibrillation, and the need for reinterventions).